Ryutaro Hirose. Show Affiliations »
Abstract
Mesh： See more » Antibodies, Monoclonal/therapeutic useBasiliximabHepatitis C/epidemiologyHumansImmunosuppression/adverse effectsImmunosuppressive Agents/therapeutic useLiver Transplantation/immunologyReceptors, Interleukin-2/immunologyRecombinant Fusion ProteinsRecurrence
Substances： See more » Antibodies, MonoclonalImmunosuppressive AgentsReceptors, Interleukin-2Recombinant Fusion ProteinsBasiliximab
Year: 2002 PMID： 11862590 DOI： 10.1053/jlts.2002.31384
Source DB: PubMed Journal: Liver Transpl ISSN： 1527-6465 Impact factor: 5.799